Filters
Development of saliva field immunochemical test for detection of Kratom and new phytocannabinoid intoxication (VB02000042)
Kratom and new phytocannabinoids such as HHC, THCP have become a very significant phenomenon in recent years. All products containing these substances are sold without any restrictions and thus a very large user base has been formed. Despite...
Analytical chemistry
- 2024 - 2026 •
- 23 485 tis. Kč •
- 16 440 tis. Kč •
- MV
Řešení projektu: 1. 1. 2024 - 31. 12. 2026
Uznané náklady
Podpora ze státního rozpočtu (70%)
Poskytovatel: Ministerstvo vnitra
Anti-inflammatory properties of bioactive compounds isolated from Cannabis sativa L. (GA22-20860S)
Phytocannabinoids, secondary metabolites of Cannabis sativa L., represent a unique group of compounds showing numerous health beneficial biological effects, including the anti-inflammatory one. At the same time, the low-grade inflammation ob...
Food and beverages
- 2022 - 2024 •
- 12 342 tis. Kč •
- 11 490 tis. Kč •
- GA ČR
Řešení projektu: 1. 1. 2022 - 31. 12. 2024
Uznané náklady
Podpora ze státního rozpočtu (93%)
Poskytovatel: Grantová agentura České republiky
Biotechnology of hemp cultivation for CBD products (FV40103)
Aim of the project is research of new progressibve cultivation procedures for selected hemp cultivars characterized by high content of bioactive compounds. Procedures should reduce use of fungicides and maximize production of phytocannabinoids
Environmental biotechnology
- 2019 - 2022 •
- 24 372 tis. Kč •
- 15 169 tis. Kč •
- MPO
Řešení projektu: 1. 7. 2019 - 31. 12. 2022
Uznané náklady
Podpora ze státního rozpočtu (62%)
Poskytovatel: Ministerstvo průmyslu a obchodu
Health risk of sub-chronic phytocannabinoids application (NW24-09-00244)
Preparations containing phytocannabinoids (PCBs) are very popular and are widely used orally, dermally or inhaled, mainly for their anti-inflammatory and analgesic effects. Most users consider non-psychotropic PCBs to be free of health risks...
Dermatology and venereal diseases
- 2024 - 2027 •
- 12 574 tis. Kč •
- 12 574 tis. Kč •
- MZ
Řešení projektu: 1. 5. 2024 - 31. 12. 2027
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 4 out of 4